We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Genentech raises stakes on PARP inhibitors.
- Authors
Sheridan, Cormac
- Abstract
The article reports on the participation of Genentech Inc., a San Francisco-based biotechnology company, in the clinical development of poly-polymerase (PARP) inhibitors. On July 25, 2006, the company has announced that it had entered a drug development agreement with Massachusetts-based biotechnology company Inotek Pharmaceuticals Corp. for the development of PARP inhibitors.
- Subjects
UNITED States; GENENTECH Inc.; RESEARCH &; development; BUSINESS partnerships; STRATEGIC alliances (Business); INOTEK Pharmaceuticals Corp.; BIOTECHNOLOGY industries
- Publication
Nature Biotechnology, 2006, Vol 24, Issue 10, p1179
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt1006-1179